Alzheimer model for drug screening
US6548261B1 · kind B1 · utility
8Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 1998 |
| Grant date | Apr 15, 2003 |
| Priority date | — |
| Expiry date | Dec 30, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to methods and reagents for drug screening. Screening methods are disclosed employing neuronal cells that have been treated so as to exhibit characteristics associated with a re-entry into the cell cycle. One treatment approach comprises transfection of neuronal cells with an expression vector comprising one or more oncogenes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.